David Ezra
Impact in
- Cell Biology top 1%
- Plant Pathogens and Fungal Diseases
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
Papers in
- Cell Biology 40
- Plant Pathogens and Fungal Diseases 40
- Pharmacology 18
- Microbial Natural Products and Biosynthesis 8
- Co-authors
- Gary A. StrobelHillel HalkinJoe SearsRobert E. GoldsteinOrna LiarziDavid OlchovskyShlomo AlmogW. M. Hess
- Journals
- Plant Disease (9 papers)European Journal of Pharmacology (4 papers)Microbiology (4 papers)Prostaglandins (3 papers)The American Journal of Medicine (3 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
David Ezra
135 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 163
- Cell Biology 891
- Pharmacology 739
- Media Technology 275
- Plant Science 1.1k
- Internal Medicine 101
Countries citing papers authored by David Ezra
This map shows the geographic impact of David Ezra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ezra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ezra more than expected).
Fields of papers citing papers by David Ezra
This network shows the impact of papers produced by David Ezra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ezra. The network helps show where David Ezra may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Ezra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 1 | |
| 8 | 2017 | 17 | |
| 9 | 2017 | 33 | |
| 10 | 2016 | 69 | |
| 11 | The use of Spiroplasma melliferum as a model organism to study the antagonistic activity of grapevine endophytes against phytoplasma | 2011 | 5 |
| 12 | The endophytic fungal complex of Catharanthus roseus (L.) G. Don | 2008 | 83 |
| 13 | Applying an artificial neural network to warfarin maintenance dose prediction. | 2004 | 23 |
| 14 | 1999 | 40 | |
| 15 | 1999 | 2 | |
| 16 | 1993 | 23 | |
| 17 | 1992 | 31 | |
| 18 | 1992 | 2 | |
| 19 | 1991 | 1 | |
| 20 | 1990 | 15 |
About David Ezra
David Ezra is a scholar working on Cell Biology, Pharmacology, Horticulture, Plant Science and Media Technology, having authored 139 papers that have together received 4.0k indexed citations. Recurring topics across this work include Plant Pathogens and Fungal Diseases (40 papers), Plant-Microbe Interactions and Immunity (11 papers), Plant Pathogenic Bacteria Studies (8 papers), Microbial Natural Products and Biosynthesis (8 papers), Atrial Fibrillation Management and Outcomes (8 papers), Fungal Plant Pathogen Control (8 papers), Advanced Optical Imaging Technologies (8 papers) and Asthma and respiratory diseases (7 papers). The work is most often cited by research in Cell Biology (891 citations), Pharmacology (739 citations), Media Technology (275 citations), Plant Science (1.1k citations) and Internal Medicine (101 citations) David Ezra has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Gary A. Strobel, Hillel Halkin, Joe Sears, Robert E. Goldstein, Orna Liarzi, David Olchovsky, Shlomo Almog, W. M. Hess, Nicolas S. Holliman and Aharon Lubetsky. Their work appears in journals such as Plant Disease, European Journal of Pharmacology, Microbiology, Prostaglandins and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.